{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T18:59:11Z","timestamp":1789412351678,"version":"build-2803163510"},"reference-count":37,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2004,1,1]],"date-time":"2004-01-01T00:00:00Z","timestamp":1072915200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Chest"],"published-print":{"date-parts":[[2004,1]]},"DOI":"10.1378\/chest.125.1.112","type":"journal-article","created":{"date-parts":[[2004,1,13]],"date-time":"2004-01-13T00:28:25Z","timestamp":1073953705000},"page":"112-117","source":"Crossref","is-referenced-by-count":209,"title":["Aldosterone Excretion Among Subjects With Resistant Hypertension and Symptoms of Sleep Apnea"],"prefix":"10.1016","volume":"125","author":[{"given":"David A.","family":"Calhoun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mari K.","family":"Nishizaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad A.","family":"Zaman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan M.","family":"Harding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1378\/chest.125.1.112_bib1","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1056\/NEJM200005113421901","article-title":"Prospective study of the association between sleep-disordered breathing and hypertension","volume":"342","author":"Peppard","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.125.1.112_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00004872-200112000-00022","article-title":"High prevalence of unrecognized sleep apnoea in drug-resistant hypertension","volume":"19","author":"Logan","year":"2001","journal-title":"J Hypertens"},{"key":"10.1378\/chest.125.1.112_bib3","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1093\/sleep\/24.6.721","article-title":"Sleep apnea syndrome: a possible contributing factor to resistant hypertension","volume":"24","author":"Lavie","year":"2001","journal-title":"Sleep"},{"key":"10.1378\/chest.125.1.112_bib4","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.7326\/0003-4819-66-6-1079","article-title":"Hypokalemia in the hypertensive patient-with observations on the incidence of primary aldosteronism","volume":"66","author":"Kaplan","year":"1967","journal-title":"Ann Intern Med"},{"key":"10.1378\/chest.125.1.112_bib5","first-page":"187","article-title":"The incidence rate of phaeochromocytoma and Conn's syndrome in Denmark, 1977\u20131981","volume":"2","author":"Andersen","year":"1988","journal-title":"J Hum Hypertens"},{"key":"10.1378\/chest.125.1.112_bib6","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/j.1440-1681.1994.tb02519.x","article-title":"High incidence of primary aldosteronism in 199 patients referred with hypertension","volume":"21","author":"Gordon","year":"1994","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1378\/chest.125.1.112_bib7","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/j.1440-1681.1993.tb01687.x","article-title":"Evidence that primary aldosteronism may not be uncommon: 12% incidence among antihypertensive drug trial volunteers","volume":"20","author":"Gordon","year":"1993","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1378\/chest.125.1.112_bib8","first-page":"1863","article-title":"Primary hyperaldosteronism in essential hypertensives: prevalence, biochemical profile, and molecular biology","volume":"85","author":"Fardella","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1378\/chest.125.1.112_bib9","first-page":"394","article-title":"The aldosterone\/renin ratio as a screening test for primary aldosteronism","volume":"90","author":"Rayner","year":"2000","journal-title":"S Afr Med J"},{"key":"10.1378\/chest.125.1.112_bib10","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/sj.jhh.1001013","article-title":"High prevalence of primary aldosteronism in the Tayside hypertension clinic population","volume":"14","author":"Lim","year":"2000","journal-title":"J Hum Hypertens"},{"key":"10.1378\/chest.125.1.112_bib11","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S0140-6736(05)74868-6","article-title":"Potentially high prevalence of primary aldosteronism in a primary-care population [letter]","volume":"353","author":"Lim","year":"1999","journal-title":"Lancet"},{"key":"10.1378\/chest.125.1.112_bib12","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/S0895-7061(02)02969-2","article-title":"High prevalence of primary aldosteronism using postcaptopril plasma aldosterone to renin ratio as a screening test among Italian hypertensives","volume":"15","author":"Rossi","year":"2002","journal-title":"Am J Hypertens"},{"key":"10.1378\/chest.125.1.112_bib13","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1161\/01.HYP.0000040261.30455.B6","article-title":"High prevalence of primary aldosteronism among black and white subjects with resistant hypertension","volume":"40","author":"Calhoun","year":"2002","journal-title":"Hypertension"},{"key":"10.1378\/chest.125.1.112_bib14","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1524-6175.2001.00496.x","article-title":"Primary aldosteronism: a practical approach to diagnosis and treatment","volume":"3","author":"Thakkar","year":"2001","journal-title":"J Clin Hypertens"},{"key":"10.1378\/chest.125.1.112_bib15","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1097\/00045415-199907000-00012","article-title":"Primary aldosteronism: a common and curable form of hypertension","volume":"7","author":"Young","year":"1999","journal-title":"Cardiol Rev"},{"key":"10.1378\/chest.125.1.112_bib16","doi-asserted-by":"crossref","first-page":"485","DOI":"10.7326\/0003-4819-131-7-199910050-00002","article-title":"Using the Berlin Questionnaire to identify patients at risk for the sleep apnea syndrome","volume":"131","author":"Netzer","year":"1999","journal-title":"Ann Intern Med"},{"key":"10.1378\/chest.125.1.112_bib17","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1164\/rccm.2109080","article-title":"Epidemiology of obstructive sleep apnea: a population health perspective","volume":"165","author":"Young","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1378\/chest.125.1.112_bib18","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1164\/ajrccm.160.6.9811054","article-title":"Sleep-related breathing disorder is an independent risk factor for systemic hypertension","volume":"160","author":"Grote","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1378\/chest.125.1.112_bib19","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1152\/jappl.1995.79.1.151","article-title":"Immediate effects of arousal from sleep on cardiac autonomic outflow in the absence of breathing in dogs","volume":"79","author":"Horner","year":"1995","journal-title":"J Appl Physiol"},{"key":"10.1378\/chest.125.1.112_bib20","first-page":"377","article-title":"The effect of sleep apnea on plasma and urinary catecholamines","volume":"18","author":"Dimsdale","year":"1995","journal-title":"Sleep"},{"key":"10.1378\/chest.125.1.112_bib21","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/00004872-199917010-00010","article-title":"Effects of obstructive sleep apnea on endothelin-1 and blood pressure","volume":"17","author":"Phillips","year":"1999","journal-title":"J Hypertens"},{"key":"10.1378\/chest.125.1.112_bib22","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1161\/01.HYP.20.5.612","article-title":"Sympathetic denervation blocks blood pressure elevation in episodic hypoxia","volume":"20","author":"Flectcher","year":"1992","journal-title":"Hypertension"},{"key":"10.1378\/chest.125.1.112_bib23","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1378\/chest.103.6.1763","article-title":"Augmented resting sympathetic activity in awake patients with obstructive sleep apnea","volume":"103","author":"Carlson","year":"1993","journal-title":"Chest"},{"key":"10.1378\/chest.125.1.112_bib24","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0165-1838(99)00039-9","article-title":"Effects of treatment of obstructive sleep apnea on circadian hemodynamics","volume":"77","author":"Voogel","year":"1999","journal-title":"J Auton Nerv Syst"},{"key":"10.1378\/chest.125.1.112_bib25","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.1161\/01.CIR.100.23.2332","article-title":"Nocturnal continuous positive airway pressure decreases daytime sympathetic traffic in obstructive sleep apnea","volume":"100","author":"Narkiewicz","year":"1999","journal-title":"Circulation"},{"key":"10.1378\/chest.125.1.112_bib26","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/S0272-6386(01)80117-7","article-title":"Screening for primary aldosteronism without discontinuing hypertensive medications: plasma aldosterone-renin ratio","volume":"37","author":"Gallay","year":"2001","journal-title":"Am J Kidney Dis"},{"key":"10.1378\/chest.125.1.112_bib27","first-page":"R431","article-title":"Renin, ACTH, and aldosterone during acute hypercapnia and hypoxia in conscious rats","volume":"254","author":"Raff","year":"1988","journal-title":"Am J Physiol"},{"key":"10.1378\/chest.125.1.112_bib28","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/S0895-7061(96)00252-X","article-title":"Pressure-heart rate responses to \u03b1-adrenergic stimulation and hormonal regulation in normotensive patients with obstructive sleep apnea","volume":"10","author":"Maillard","year":"1997","journal-title":"Am J Hypertens"},{"key":"10.1378\/chest.125.1.112_bib29","first-page":"211","article-title":"Obstructive sleep apnea treatment: peripheral and central effects on plasma renin activity and aldosterone","volume":"14","author":"Follenius","year":"1991","journal-title":"Sleep"},{"key":"10.1378\/chest.125.1.112_bib30","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1046\/j.1365-2869.1996.t01-1-00007.x","article-title":"Effect of CPAP treatment on plasma volume, aldosterone and 24-h blood pressure in obstructive sleep apnea","volume":"5","author":"Saarelainen","year":"1996","journal-title":"J Sleep Res"},{"key":"10.1378\/chest.125.1.112_bib31","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1001\/jama.289.17.2230","article-title":"Incidence of sleep-disorder breathing in an urban adult population: the relative importance of risk factors in the development of sleep-disordered breathing","volume":"289","author":"Tishler","year":"2003","journal-title":"JAMA"},{"key":"10.1378\/chest.125.1.112_bib32","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1164\/ajrccm.155.1.9001310","article-title":"Racial differences in sleep-disordered breathing in African-Americans and Caucasians","volume":"155","author":"Redline","year":"1997","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1378\/chest.125.1.112_bib33","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1056\/NEJM198104163041602","article-title":"The effect of weight reduction on blood pressure, plasma renin activity, and plasma aldosterone levels in obese patients","volume":"304","author":"Tuck","year":"1981","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.125.1.112_bib34","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1161\/01.HYP.4.5.686","article-title":"Blood pressure and hormone changes associated with weight reduction in the obese","volume":"4","author":"Sowers","year":"1982","journal-title":"Hypertension"},{"key":"10.1378\/chest.125.1.112_bib35","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1093\/ajh\/7.10.886","article-title":"Renin and aldosterone are higher and the hyperinsulinemic effect of salt restriction greater in subjects with risk factors clustering","volume":"7","author":"Egan","year":"1994","journal-title":"Am J Hypertens"},{"key":"10.1378\/chest.125.1.112_bib36","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S0952-3278(99)80020-9","article-title":"Plasma aldosterone, plasma lipoproteins, obesity and insulin resistance in humans","volume":"60","author":"Goodfriend","year":"1999","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"10.1378\/chest.125.1.112_bib37","doi-asserted-by":"crossref","first-page":"789","DOI":"10.3109\/07435809809032689","article-title":"Aldosterone in obesity","volume":"24","author":"Goodfriend","year":"1998","journal-title":"Endocr Res"}],"container-title":["Chest"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369215317815?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369215317815?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,15]],"date-time":"2019-02-15T16:57:59Z","timestamp":1550249879000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0012369215317815"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,1]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2004,1]]}},"alternative-id":["S0012369215317815"],"URL":"https:\/\/doi.org\/10.1378\/chest.125.1.112","relation":{},"ISSN":["0012-3692"],"issn-type":[{"value":"0012-3692","type":"print"}],"subject":[],"published":{"date-parts":[[2004,1]]}}}